Utah Medical Products, Inc. Terminates its Shareholder Rights Agreement
March 01 2021 - 10:00AM
via NewMediaWire -- Utah Medical Products, Inc. (Nasdaq: UTMD)
announces that its Board of Directors, acting by unanimous written
consent, terminated the Company’s Shareholder Rights Agreement,
sometimes referred to as a “poison pill.” The Rights
Agreement with a ten year life was originally approved by a vote of
all shareholders at the 1994 Annual Meeting, and then was extended
in 2004 and again in 2014 by the board without a shareholder vote.
The board elected to terminate the rights agreement in response to
changing corporate governance practices and investor input.
Utah Medical Products, Inc., with particular
interest in health care for women and their babies, develops,
manufactures and markets a broad range of disposable and reusable
specialty medical devices recognized by clinicians in over a
hundred countries around the world as the standard for obtaining
optimal long term outcomes for their patients. For more
information about Utah Medical Products, Inc., visit UTMD’s website
athttp://www.utahmed.com.
Contact: Crystal Rios(801)
566-1200
Utah Medical Products (NASDAQ:UTMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Utah Medical Products (NASDAQ:UTMD)
Historical Stock Chart
From Sep 2023 to Sep 2024